Survivors and nonsurvivors of very prolonged status epilepticus

Epilepsy and Behavior

Volumn 22, Issue 2, 2011, Pages 342-345

  Drislane, Frank W ^a   Lopez, M Raquel ^b   Blum, Andrew S ^c   Schomer, Donald L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Coma; Futility; Intensive care unit; Nonconvulsive status epilepticus; Predictive factors; Prognosis; Status epilepticus; Treatment

Indexed keywords

CARBAMAZEPINE; LORAZEPAM; MIDAZOLAM; PARALDEHYDE; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; AGED; ALERTNESS; ANTICONVULSANT THERAPY; ARTICLE; BRAIN BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMA; COMORBIDITY; COMPLEX PARTIAL SEIZURE; CONFUSION; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE DURATION; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; GASTROINTESTINAL HEMORRHAGE; GENERALIZED EPILEPSY; GRAND MAL SEIZURE; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LETHARGY; LOBECTOMY; LONG TERM CARE; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MENTAL DISEASE; METABOLIC DISORDER; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; STUPOR; SURVIVOR; TEMPORAL LOBE; TOXOPLASMOSIS; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; URINARY TRACT INFECTION; WAKEFULNESS;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMA; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 80053386940     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.07.013     Document Type: Article

References (24)

1. Towne A.R., Pellock J.M., Ko D., DeLorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27-34.
2. DeLorenzo R.J., Hauser W.A., Towne A.R., et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029-1035.
3. Logroscino G., Hesdorffer D.C., Cascino G., Annegers J.F., Hauser W.A. Short-term mortality after a first episode of status epilepticus. Epilepsia 1997, 38:1344-1349.
4. Rossetti A.O., Hurwitz S., Logroscino G., Bromfield E.B. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006, 77:611-615.
5. Drislane F.W., Blum A.S., Lopez M.R., Schomer D.L. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009, 50:1566-1571.
6. Barry E., Hauser W.A. Status epilepticus: the interaction of epilepsy and acute brain disease. Neurology 1993, 43:1473-1478.
7. Delanty N., French J.A., Labar D.R., Pedley T.A., Rowan A.J. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure 2001, 10:116-119.
8. Holtkamp M., Othman J., Buchheim K., Masuhr F., Schielke E., Meierkord H. A "malignant" variant of status epilepticus. Arch Neurol 2005, 62:1428-1431.
9. Claassen J., Lokin J.K., Fitzsimmons B.F.M., Mendelsohn F.A., Mayer S.A. Predictors of functional disability and mortality after status epilepticus. Neurology 2002, 58:139-142.
10. Shneker B.F., Fountain N.B. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003, 61:1066-1073.
11. Mirski M.A., Williams M.A., Hanley D.F. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 1995, 23:400-404.
12. Krishnamurthy K.B., Drislane F.W. Phenobarbital and benzodiazepine assisted withdrawal of prolonged pentobarbital treatment for refractory status epilepticus. J Epilepsy 1997, 10:211-214.
13. Cooper A.D., Britton J.W., Rabinstein A.A. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol 2009, 66:1505-1509.
14. Dara S.I., Tungpalan L.A., Manno E.M., et al. Prolonged coma from refractory status epilepticus. Neurocrit Care 2006, 4:140-142.
15. Lowenstein D.H., Aminoff M.A. Clinical and EEG features of status epilepticus in comatose patients. Neurology 1992, 42:100-104.
16. Lowenstein D.H., Alldredge B.K. Status epilepticus at an urban public hospital in the 1980's. Neurology 1993, 43:483-488.
17. Sahin M., Menache C.C., Holmes G.L., Riviello J.J. Outcome of severe refractory status epilepticus in children. Epilepsia 2001, 42:1461-1467.
18. Scholtes F.B., Renier W.O., Meinardi H. Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia 1994, 35:1104-1112.
19. Drislane F.W., Lopez M.R., Blum A.S., Schomer D.L. Detection and treatment of refractory status epilepticus in the intensive care unit. J Clin Neurophysiol 2008, 25:181-186.
20. Cascino G.D., Hesdorffer D., Logroscino G., Hauser W.A. Treatment of non-febrile status epilepticus in Rochester, Minn, from 1965 through 1984. Mayo Clin Proc 2001, 76:39-41.
21. Vignatelli L., Rinaldi R., Baldin E., et al. Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts. J Neurol 2008, 255:197-204.
22. Geocadin R.G., Buitrago M.M., Torbey M.T., Chandra-Strobos N., Williams M.A., Kaplan P.W. Neurologic prognosis and withdrawal of life support after resuscitation from cardiac arrest. Neurology 2006, 67:105-108.
23. Drislane F.W., Schomer D.L. Clinical implications of generalized electrographic status epilepticus. Epilepsy Res 1994, 19:111-112.
24. Rossetti A.O., Oddo M., Liaudet L., Kaplan P.W. Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology 2009, 72:744-749.